| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Selen Ünlü, Blanca G Sánchez Navarro, Elif Cakan, Daniel Berchtold, Rafael Meleka Hanna, Secil Vural, Atay Vural, Andreas Meisel, Miriam L Fichtne. Exploring the depths of IgG4: insights into autoimmunity and novel treatments. Frontiers in immunology. vol 15. 2024-05-03. PMID:38698867. |
these diseases include myasthenia gravis (mg) with autoantibodies against muscle-specific tyrosine kinase (musk), nodo-paranodopathies with autoantibodies against paranodal and nodal proteins, pemphigus vulgaris and foliaceus with antibodies against desmoglein and encephalitis with antibodies against lgi1/caspr2. |
2024-05-03 |
2024-05-05 |
Not clear |
| Olena Butenko, Stine Marie Jensen, Yvonne E Fillié-Grijpma, Robyn Verpalen, Jan J Verschuuren, Silvère M van der Maarel, Maartje G Huijbers, Jaap J Plom. Change of voltage-gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model. The European journal of neuroscience. 2024-04-23. PMID:38650308. |
change of voltage-gated sodium channel repertoire in skeletal muscle of a musk myasthenia gravis mouse model. |
2024-04-23 |
2024-04-26 |
mouse |
| Olena Butenko, Stine Marie Jensen, Yvonne E Fillié-Grijpma, Robyn Verpalen, Jan J Verschuuren, Silvère M van der Maarel, Maartje G Huijbers, Jaap J Plom. Change of voltage-gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model. The European journal of neuroscience. 2024-04-23. PMID:38650308. |
muscle-specific kinase myasthenia gravis (musk mg) is caused by autoantibodies against musk in the neuromuscular junction (nmj). |
2024-04-23 |
2024-04-26 |
mouse |
| Ting He, Kangzhi Chen, Yi Li, Zhaohui Luo, Mengchuan Luo, Huan Yan. Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China. Neuropsychiatric disease and treatment. vol 20. 2024-04-03. PMID:38566882. |
to decipher the discrepancies between muscle-specific kinase antibody-positive myasthenia gravis (musk-mg) and double-seropositive myasthenia gravis (dsp-mg), and to determine prognostic factors for minimal manifestation status (mms) achievement in mg patients with musk autoantibodies (musk-ab). |
2024-04-03 |
2024-04-05 |
Not clear |
| A Baheerathan, R Dorsey, S Viega. Oral salbutamol for symptomatic treatment in MuSK antibody-positive myasthenia gravis: a single-centre experience. Acta neurologica Belgica. 2024-04-01. PMID:38561498. |
oral salbutamol for symptomatic treatment in musk antibody-positive myasthenia gravis: a single-centre experience. |
2024-04-01 |
2024-04-04 |
Not clear |
| Tadaharu Shiozumi, Nobunaga Okada, Tasuku Matsuyama, Yoshihiro Yamahata, Bon Oht. Anti-Muscle-Specific Kinase (MuSK) Antibody-Positive Myasthenia Gravis Presenting With Dyspnea in an Elderly Woman: A Case Report. Cureus. vol 15. issue 12. 2024-01-15. PMID:38222201. |
anti-muscle-specific kinase (musk) antibody-positive myasthenia gravis presenting with dyspnea in an elderly woman: a case report. |
2024-01-15 |
2024-01-17 |
Not clear |
| Kazuhiro Shigemot. [Pathogenesis of MuSK Antibody-positive Myasthenia Gravis]. Brain and nerve = Shinkei kenkyu no shinpo. vol 76. issue 1. 2024-01-08. PMID:38191139. |
[pathogenesis of musk antibody-positive myasthenia gravis]. |
2024-01-08 |
2024-01-10 |
Not clear |
| Takayuki Kond. [Clinical Features and Pathogenesis of Double Seronegative Myasthenia Gravis]. Brain and nerve = Shinkei kenkyu no shinpo. vol 76. issue 1. 2024-01-08. PMID:38191140. |
subjects with double seronegative myasthenia gravis (dnmg) are defined as those who are seronegative to both antibodies against acetylcholine receptor (achr) and muscle-specific kinase (musk) by radioimmunoprecipitation assay (ria). |
2024-01-08 |
2024-01-10 |
human |
| Gizem Koral, Canan Ulusoy, Judith Cossins, Konstantinos Lazaridis, Recai Türkoğlu, Yin Yao Dong, Erdem Tüzün, Vuslat Yılma. Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice. Journal of neuroimmunology. vol 383. 2023-09-03. PMID:37660538. |
muscle specific kinase (musk) antibody positive myasthenia gravis (mg) often presents with a severe disease course and resistance to treatment. |
2023-09-03 |
2023-09-07 |
mouse |
| Laura Carmillo, Pierpaolo Congedo, Marcella Caggiula, Milva Maria Nuzzo, Antonio Fasan. MuSK myasthenia gravis as a manifestation of immune reconstitution inflammatory syndrome in an HIV-positive patient: a challenging diagnosis and therapeutic approach. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2023-08-18. PMID:37594551. |
musk myasthenia gravis as a manifestation of immune reconstitution inflammatory syndrome in an hiv-positive patient: a challenging diagnosis and therapeutic approach. |
2023-08-18 |
2023-09-07 |
Not clear |
| Rodrigo Martinez-Harms, Carolina Barnett, Monica Alcantara, Vera Bri. Clinical characteristics and treatment outcomes in patients with double-seronegative myasthenia gravis. European journal of neurology. 2023-08-16. PMID:37531447. |
double-seronegative myasthenia gravis (dsnmg) is defined as myasthenia gravis (mg) without detectable or low affinity antibodies to acetylcholine receptor (achr) and muscle-specific kinase (musk). |
2023-08-16 |
2023-09-07 |
Not clear |
| Michelangelo Cao, Wei-Wei Liu, Susan Maxwell, Saif Huda, Richard Webster, Amelia Evoli, David Beeson, Judith A Cossins, Angela Vincen. IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 6. 2023-08-15. PMID:37582613. |
up to 50% of patients with myasthenia gravis (mg) without acetylcholine receptor antibodies (achr-abs) have antibodies to muscle-specific kinase (musk). |
2023-08-15 |
2023-09-07 |
Not clear |
| Aigli G Vakrakou, Eleni Karachaliou, Elisabeth Chroni, Vasiliki Zouvelou, Dimitrios Tzanetakos, Stavroula Salakou, Marianna Papadopoulou, Socrates Tzartos, Konstantinos Voumvourakis, Constantinos Kilidireas, Sotirios Giannopoulos, Georgios Tsivgoulis, John Tzarto. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease. Frontiers in immunology. vol 14. 2023-08-11. PMID:37564637. |
muscle-specific kinase (musk) myasthenia gravis (mg) represents a prototypical antibody-mediated disease characterized by predominantly focal muscle weakness (neck, facial, and bulbar muscles) and fatigability. |
2023-08-11 |
2023-08-16 |
Not clear |
| Zhiguo Li, Chao Zhang, Ting Chang, Xinghu Zhang, Huan Yang, Feng Gao, Jinzhou Feng, Hongbo Liu, Sheng Chen, Lihua Wang, Chunsheng Yang, Huining Li, Yuesong Pan, Jacqueline Palace, Fu-Dong Sh. A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study. The Lancet regional health. Western Pacific. vol 38. 2023-08-09. PMID:37554174. |
laboratory determination of autoantibodies against acetylcholine receptor (achr), muscle-specific kinase (musk) and other autoantigens have been integrated into the diagnosis of myasthenia gravis (mg). |
2023-08-09 |
2023-08-16 |
Not clear |
| Jamie L Lim, Roy Augustinus, Jaap J Plomp, Kasra Roya-Kouchaki, Dana L E Vergoossen, Yvonne Fillié-Grijpma, Josephine Struijk, Rachel Thomas, Daniela Salvatori, Christophe Steyaert, Christophe Blanchetot, Roeland Vanhauwaert, Karen Silence, Silvère M van der Maarel, Jan J Verschuuren, Maartje G Huijber. Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK. Scientific reports. vol 13. issue 1. 2023-05-08. PMID:37156800. |
nmj dysfunction is a hallmark of several neuromuscular diseases, including musk myasthenia gravis. |
2023-05-08 |
2023-08-14 |
mouse |
| Jamie L Lim, Roy Augustinus, Jaap J Plomp, Kasra Roya-Kouchaki, Dana L E Vergoossen, Yvonne Fillié-Grijpma, Josephine Struijk, Rachel Thomas, Daniela Salvatori, Christophe Steyaert, Christophe Blanchetot, Roeland Vanhauwaert, Karen Silence, Silvère M van der Maarel, Jan J Verschuuren, Maartje G Huijber. Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK. Scientific reports. vol 13. issue 1. 2023-05-08. PMID:37156800. |
the most potent agonists partially rescued myasthenic effects of musk myasthenia gravis patient igg autoantibodies in vitro. |
2023-05-08 |
2023-08-14 |
mouse |
| Yohei Harada, Margaret Bettin, Vern C Juel, Lisa D Hobson-Webb, Shruti M Raja, Donald B Sanders, Janice M Masse. Pregnancy in MuSK-positive myasthenia gravis: A single-center case series. Muscle & nerve. 2023-05-07. PMID:37150596. |
myasthenia gravis (mg) with muscle-specific tyrosine kinase (musk) antibodies (mmg) is predominantly seen in women of childbearing age. |
2023-05-07 |
2023-08-14 |
Not clear |
| Amy Aitken, Supriya Kanitka. New diagnosis of myasthenia gravis in the third trimester - A case report. Case reports in women's health. vol 38. 2023-04-24. PMID:37090685. |
following one week of investigations, including spirometry, magnetic resonance imaging of brain and spine, and needle electromyography, she was diagnosed with musk (anti-muscle-specific tyrosine kinase antibodies) associated myasthenia gravis. |
2023-04-24 |
2023-08-14 |
Not clear |
| Nils Erik Gilhu. Treatment considerations in myasthenia gravis for the pregnant patient. Expert review of neurotherapeutics. 2023-02-14. PMID:36786092. |
myasthenia gravis (mg) is an autoimmune disease where muscle antibodies form against the acetylcholine receptor (achr), musk, or lrp4 at the neuromuscular junction leading to weakness. |
2023-02-14 |
2023-08-14 |
Not clear |
| Sangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, Jinmin Lee, Darshil Patel, Eun Jung Choi, Andrea Alvarado, Ebony Cottman-Thomas, Damian Maseda, Patricia Y Tsao, Christoph T Ellebrecht, Sami L Khella, David P Richman, Kevin C O'Connor, Uri Herzberg, Gwendolyn K Binder, Michael C Milone, Samik Basu, Aimee S Payn. Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. Nature biotechnology. 2023-01-19. PMID:36658341. |
muscle-specific tyrosine kinase myasthenia gravis (musk mg) is an autoimmune disease that causes life-threatening muscle weakness due to anti-musk autoantibodies that disrupt neuromuscular junction signaling. |
2023-01-19 |
2023-08-14 |
mouse |